Michael Geffner

Direttore Tecnico/Scientifico/R&S presso IMMUNOVANT, INC.

Patrimonio netto: 4 M $ in data 30/06/2024

55 anni

Health Technology

Consumer Services

Posizioni attive di Michael Geffner

Società	Posizione	Inizio	Fine
IMMUNOVANT, INC.	Direttore Tecnico/Scientifico/R&S	-	-

Società	Posizione	Inizio	Fine
BlueSphere Bio, Inc. BlueSphere Bio, Inc. Pharmaceuticals: MajorHealth Technology BlueSphere Bio, Inc. manufactures oncology drugs products. The company was founded by Mark Shlomchik, Warren Shlomchik, and Constantinos Panousis and is headquartered in Pittsburgh, PA.	Direttore Tecnico/Scientifico/R&S	01/06/2020	01/06/2022
ACHILLION PHARMACEUTICALS, INC.	Corporate Officer/Principal	01/11/2015	01/04/2020
MERCK & CO., INC.	Corporate Officer/Principal	-	-

Albany Medical College	Doctorate Degree
Fairleigh Dickinson University	Masters Business Admin

Distribuzione geografica

Stati Uniti

Posizioni

Corporate Officer/Principal	3
Chief Tech/Sci/R&D Officer	2
Doctorate Degree	1

Settori

Health Technology	5
Consumer Services	3

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	2
IMMUNOVANT, INC.	Health Technology
MERCK & CO., INC.	Health Technology

Aziende private	2
Achillion Pharmaceuticals, Inc. Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA.	Health Technology
BlueSphere Bio, Inc. BlueSphere Bio, Inc. Pharmaceuticals: MajorHealth Technology BlueSphere Bio, Inc. manufactures oncology drugs products. The company was founded by Mark Shlomchik, Warren Shlomchik, and Constantinos Panousis and is headquartered in Pittsburgh, PA.	Health Technology